Trientine tetrahydrochloride Administered once a day for the first line treatment of Wilson’s disease patients
عنوان الدراسة
Trientine tetrahydrochloride Administered once a day for the first line treatment of Wilson’s disease patients
داعم الدراسة
Orphalan
دواء الدراسة
Trientine tetrahydrochloride (TETA 4HCl)
رقم بروتوكول الدراسة
ORPH-131-017
حالة الدراسة
Ongoing
موقع الدراسة
1.King Faisal Specialist Hospital and Research Center - Riyadh
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.